Swedbank
NRIX icon

Swedbank’s Nurix Therapeutics NRIX Stock Holding History

Swedbank’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+65,000
New +$1.11M ﹤0.01% 661

Other funds holding NRIX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Swedbank's NRIX Position: Q2 2026 in Review

Swedbank opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 65,000 shares worth $1.58M. The stake represents ﹤0.01% of the portfolio and ranks #661 among its holdings.

10 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Swedbank held 65,000 shares of Nurix Therapeutics worth $1.58M as of Q2 2026.
  • Nurix Therapeutics was a new Swedbank position in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #661 holding.
  • 10 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.